Mutation analysis of EGFR and its correlation with the HPV in Indian cervical cancer patients.

about

Somatic Host Cell Alterations in HPV Carcinogenesis.Genetic and epigenetic alterations affecting PARK-2 expression in cervical neoplasm among North Indian patients.

P2860

Q40096622-CF89C8D1-E526-41C3-8045-AA1B677670CE Q48593906-16BE653A-F7D7-43B0-9FD5-6EA3B9415C43

P2860

Mutation analysis of EGFR and its correlation with the HPV in Indian cervical cancer patients.

Item

http://www.wikidata.org/entity/Q38804094

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Mutation analysis of EGFR and ...... dian cervical cancer patients.

@en

type

Item

label

Mutation analysis of EGFR and ...... dian cervical cancer patients.

@en

prefLabel

Mutation analysis of EGFR and ...... dian cervical cancer patients.

@en

P1476

Mutation analysis of EGFR and ...... ndian cervical cancer patients

@en

P2093

Afreen Naseem

http://www.w3.org/2001/XMLSchema#string

Ahmad Perwez

http://www.w3.org/2001/XMLSchema#string

Gauri Gandhi

http://www.w3.org/2001/XMLSchema#string

Himanshu Arora

http://www.w3.org/2001/XMLSchema#string

Rehana Qureshi

http://www.w3.org/2001/XMLSchema#string

Saima Wajid

http://www.w3.org/2001/XMLSchema#string

Shilpi Biswas

http://www.w3.org/2001/XMLSchema#string

P2860

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

The causal relation between human papillomavirus and cervical cancer.

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data

Molecular characterization of EGFR, PDGFRA and VEGFR2 in cervical adenosquamous carcinoma.

EGFR and cancer prognosis.

Approval summary for erlotinib for treatment of patients with locally advanced or metastatic non-small cell lung cancer after failure of at least one prior chemotherapy regimen.

Why the epidermal growth factor receptor? The rationale for cancer therapy.

Expression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer.

P2888

s13277-016-4789-4

P304

9089-9098

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-016-4789-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

M Moshahid A Rizvi

P577

2016-01-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

290443490

http://www.w3.org/2001/XMLSchema#string

P6179

1019209782

http://www.w3.org/2001/XMLSchema#string

P698

26762413

http://www.w3.org/2001/XMLSchema#string

P921

India

Mutation analysis of EGFR and its correlation with the HPV in Indian cervical cancer patients.

about

P2860

P2860

Mutation analysis of EGFR and its correlation with the HPV in Indian cervical cancer patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P5875

P6179

P698

P921